Subscribe
Subscribe

Belgium

Cancer diagnosis and therapy in one: Precirix tackles tumors with camelid antibodies

A new drug that can identify tumors, trace metastases, and treat cancer – all in one? Belgian start-up Precirix is aiming high with its lead compound – a precision radiopharmaceutical using camelid antibodies to bind to, and irradiate, cancer cells.

Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception

Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. The Aurora test, developed by the Belgian start-up Fertiga, now further improves the odds for couples wanting to be parents: the test doubles the chances of becoming pregnant after just one fertility treatment.

Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices

Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications.

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders

Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with light sensitivity or ocular disorders. The company has announced the closing of its Series A funding round, comprised of € 6.2 million in equity and € 1.8 million as a non-dilutive grant.

Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

SciMingo: bringing science to the center stage

The world needs more quality science communication. The value to society is evident, as clear communication is key to science-based policy and incentivizing funding for innovation. But does science communication help the individual researchers themselves? And what can be done to encourage public outreach?

Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics

Trusting gut bacteria: MRM Health develops microbiome treatments for IBD and more

In the last decade, there has been a growing interest in the potential of microbiome-based therapeutics: using gut bacteria as a medication to battle a wide array of diseases. Ghent-based start-up MRM Health is an important innovator in this growing field, building on the expertise of sister company ProDigest and of prominent partners such as VIB and DuPont Nutrition Biosciences. In the coming months, MRM Health is starting clinical trials for a drug candidate for ulcerative colitis, a type of inflammatory bowel disease (IBD).

Ground-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience

Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the ground-breaking projects of Materialise, imec, Health House, Rega Institute KU Leuven, Brussels Airport and B-PHOT Brussels Photonics.

Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

Pulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch

Leuven, Belgium, 4 May 2021 - Pulsify Medical is a digital medical technology company developing wearable ultrasound patches which will monitor vital organs in real-time. The new and disruptive technology will address a serious unmet need for continuous cardiac monitoring in ICUs, hospitals, and homes across the world

Belgian pharma industry among the EU’s strongest despite pandemic setbacks

How did the Belgian chemical and pharmaceutical sector fare during the first year of the pandemic? A report from essenscia gives insight into the financial downturn caused by the global crisis in 2020, but also showed strong positive trends in job creation and innovation. There were record investments in research and development, particularly in the healthcare sector, which continues to score among the best in Europe.

Beer, bread and bioethanol: SUPERYEAST project to improve industry sustainability

Prof. Kevin Verstrepen, of the VIB-KU Leuven Center for Microbiology, has received a prestigious ERC Proof of Concept grant for the SUPERYEAST project. The goal is to develop industrial yeast strains that are easier to grow, which would increase the efficiency and sustainability of processes in a whole array of sectors. Notably, the research could enhance the production of fermented beverages like beer and wine, foods including bread and chocolate, and fuels like bioethanol.